Similarly, downregulation of FXN and/or Pgc-1α in the FRDA patients’ fibroblasts and mouse models have shown significant decrease in the Sod2 and other ROS antioxidant gene expression levels [34], [55], [60]. Here, PPARGC1A is linked to Friedreich ataxia.